Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L04AC15 |
UNII: | 640443FU93 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Interleukin-6 inhibitor | PubMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
Giant Cell Arteritis | 3 | D013700 | ClinicalTrials |
Polymyalgia Rheumatica | 3 | D011111 | ClinicalTrials |
Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Asthma | 2 | D001249 | ClinicalTrials |
Lupus Nephritis | 2 | D008181 | ClinicalTrials |
Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
Lupus Erythematosus, Cutaneous | 1 | D008178 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1194585-53-9 |
ChEMBL | CHEMBL1743071 |
FDA SRS | 640443FU93 |
Guide to Pharmacology | 7989 |